rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 
Rediff.com  » Cricket » Asif leaves for Geneva for 'B' sample test

Asif leaves for Geneva for 'B' sample test

August 16, 2008 17:19 IST

Desperate to prove his innocence in the Indian Premier League doping scam, embattled Pakistan pacer Mohammad Asif and his lawyer have left for Geneva, Switzerland on Friday night, where his "B" sample test will be conducted on Monday.

Asif, who tested positive for a performance-enhancing drug during the IPL, would come to know whether he faces more disciplinary action or not only after the "B" sample test.

Asif's lawyer Shahid Karim has informed that they have hired a British sports medicine specialist Dr Graham Durgan who would accompany them to ensure that the test is conducted under specifications of the World Anti-Doping Agency rules.

"We have obtained the best possible help to assist us in the case as Asif is adamant he is innocent," Karim said.

Although the pacer -- who spent 19-days in detention in Dubai airport for carrying a banned substance while returning home from India after playing in the IPL -- has a tainted past, he said he is mentally prepared to face every situation and insists that he never did anything wrong in his career.

"We are having the 'B' sample test for the reconfirmation. And we have to be present there. Inshallah! I will be cleared," said Asif, who tested positive along with fellow paceman Shoaib Akhtar for banned substance Nandrolone in 2006 before the Champions Trophy, but escaped bans after an Appellate Tribunal cleared them on technical grounds.

Asif is presently suspended by the Pakistan Cricket Board and was not selected in next month's Champions Trophy squad, but he maintained he would come out clean and earn his place back in the national team.

"If I am cleared which I am confident I will be, I will try to make a place for myself in the Pakistan team as soon as possible," he said.

© Copyright 2014 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.